Literature DB >> 18060471

Epidemiology of colorectal cancer: the 21-year experience of a specialised registry.

M Ponz de Leon1, G Rossi, C di Gregorio, C De Gaetani, F Rossi, G Ponti, L Pecone, M Pedroni, L Roncucci, A Pezzi, P Benatti.   

Abstract

UNLABELLED: Cancer registries can be viewed as one of the main strategies for improving our understanding of cancer, as they may reveal the importance of specific trends in cancer incidence and survival; in addition, the information obtained from the registries can be translated into preventive measures that might lead to a better control of neoplasms. A colorectal cancer registry was instituted in Northern Italy in 1984. The purpose of this study is to provide a description of the main findings observed in a 21-year period of continuous registration.
RESULTS: A total of 3951 malignancies of the large bowel were registered in 3817 patients, for a crude incidence rate of 75.1/100 000/year in men and 59.0 in women. Overall incidence (crude and age-adjusted) of colorectal tumours increased remarkably throughout the registration period. This increase was mainly due to early (Stage I and II) tumours and to lesions with lymph nodal involvement (Stage III). There was a tendency over time towards a progressive increase of colonic tumours, whereas the fraction of rectal neoplasms tended to decline. Colorectal cancer-specific survival increased significantly over time in each of the main TNM/Dukes classes (p<0.006 and <0.001 for Stage II and III tumours). Finally, surgery for colorectal tumours showed a tendency towards large operations (colectomy and hemicolectomy), which was parallel to a definite improvement of pathological staging.
CONCLUSIONS: Despite the increasing incidence of colorectal cancer, there are several reasons for cautious optimism. Most of the lesions are now diagnosed at an early stage, and this is associated with a significant increase of survival. The disease is undoubtedly cured better than in the past; the main challenge for future years is to achieve a sustained reduction of mortality for colorectal neoplasms.

Entities:  

Mesh:

Year:  2007        PMID: 18060471     DOI: 10.1007/s11739-007-0077-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  40 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  Is there a true "shift" to the right colon in the incidence of colorectal cancer?

Authors:  Linda Rabeneck; Jessica A Davila; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

4.  Epidemiologic panorama of colorectal cancer in Mexico, 1980-1993.

Authors:  V Tovar-Guzmán; M Flores-Aldana; J Salmerón-Castro; E C Lazcano-Ponce
Journal:  Dis Colon Rectum       Date:  1998-02       Impact factor: 4.585

5.  Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition.

Authors:  Teresa Norat; Sheila Bingham; Pietro Ferrari; Nadia Slimani; Mazda Jenab; Mathieu Mazuir; Kim Overvad; Anja Olsen; Anne Tjønneland; Francoise Clavel; Marie-Christine Boutron-Ruault; Emmanuelle Kesse; Heiner Boeing; Manuela M Bergmann; Alexandra Nieters; Jakob Linseisen; Antonia Trichopoulou; Dimitrios Trichopoulos; Yannis Tountas; Franco Berrino; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; H Bas Bueno-de-Mesquita; Petra H M Peeters; Dagrun Engeset; Eiliv Lund; Guri Skeie; Eva Ardanaz; Carlos González; Carmen Navarro; J Ramón Quirós; María-José Sanchez; Göran Berglund; Irene Mattisson; Göran Hallmans; Richard Palmqvist; Nicholas E Day; Kay-Tee Khaw; Timothy J Key; Miguel San Joaquin; Bertrand Hémon; Rodolfo Saracci; Rudolf Kaaks; Elio Riboli
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

6.  Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium.

Authors:  H Brenner; C Stegmaier; H Ziegler
Journal:  Ann Oncol       Date:  2005-04-22       Impact factor: 32.976

7.  Increasing mortality rates of common malignancies in Colombia: an emerging problem.

Authors:  Marion Piñeros; Gustavo Hernández; Freddie Bray
Journal:  Cancer       Date:  2004-11-15       Impact factor: 6.860

8.  Colon cancer in France: evidence for improvement in management and survival.

Authors:  C Faivre-Finn; A-M Bouvier-Benhamiche; J M Phelip; S Manfredi; V Dancourt; J Faivre
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry.

Authors:  M Ponz de Leon; R Sassatelli; P Benatti; L Roncucci
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  8 in total

1.  Impact of using elastic stains for detection of venous invasion in the prognosis of patients with lymph node negative colorectal cancer.

Authors:  Daniel Baumhoer; Thore Thiesler; Christoph A Maurer; Andreas Huber; Gieri Cathomas
Journal:  Int J Colorectal Dis       Date:  2010-02-09       Impact factor: 2.571

Review 2.  Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature.

Authors:  Carmela Di Gregorio; Luca Reggiani Bonetti; Carmela de Gaetani; Monica Pedroni; Shaniko Kaleci; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2012-03-27       Impact factor: 3.397

3.  No effects of olive oils with different phenolic content compared to corn oil on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.

Authors:  Angelo Pietro Femia; Piero Dolara; Maurizio Servili; Sonia Esposto; Agnese Taticchi; Stefania Urbani; Augusto Giannini; Maddalena Salvadori; Giovanna Caderni
Journal:  Eur J Nutr       Date:  2008-08-01       Impact factor: 5.614

4.  Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry.

Authors:  Maurizio Ponz de Leon; Annalisa Pezzi; Piero Benatti; Antonio Manenti; Giuseppina Rossi; Carmela di Gregorio; Luca Roncucci
Journal:  Int J Colorectal Dis       Date:  2009-03-11       Impact factor: 2.571

5.  The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.

Authors:  Corrado R Asteria; Salvatore Pucciarelli; Leonardo Gerard; Nicola Mantovani; Mauro Pagani; Luigi Boccia; Paolo Ricci; Luigi Troiano; Giuseppe Lucchini; Coriolano Pulica
Journal:  Int J Colorectal Dis       Date:  2015-08-09       Impact factor: 2.571

6.  Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population.

Authors:  Marion Chauvenet; Vanessa Cottet; Côme Lepage; Valérie Jooste; Jean Faivre; Anne-Marie Bouvier
Journal:  BMC Cancer       Date:  2011-06-30       Impact factor: 4.430

7.  Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.

Authors:  Milan Jovanovic; Nevena Gajovic; Natasa Zdravkovic; Marina Jovanovic; Milena Jurisevic; Danilo Vojvodic; Veljko Maric; Aleksandar Arsenijevic; Ivan Jovanovic
Journal:  Mediators Inflamm       Date:  2018-04-04       Impact factor: 4.711

8.  The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course.

Authors:  A Taddei; F Castiglione; M N Ringressi; E Niccolai; L Tofani; L Boni; P Bechi; A Amedei
Journal:  Mediators Inflamm       Date:  2015-10-18       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.